Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment

Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency

(2013) Danny Ka-Ho Wong et al.   Clinical Gastroenterology and Hepatology

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

(2013) Stuart C. Gordon et al.   HEPATOLOGY

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

(2013) Wai-Kay Seto et al.   HEPATOLOGY

773 SERUM HEPATITIS B SURFACE ANTIGEN LEVELS TO GUIDE THE CESSATION OF ENTECAVIR IN HEPATITIS B e ANTIGEN-NEGATIVE CHRONIC HEPATITIS B: AN INTERIM ANALYSIS

(2013) W.-K. Seto et al.   JOURNAL OF HEPATOLOGY

Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B

(2012) Anna S. Lok et al.   GASTROENTEROLOGY

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

(2012) Tai–Chung Tseng et al.   GASTROENTEROLOGY

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance

(2012) Wai-Kay Seto et al.   HEPATOLOGY

Future Prevention and Treatment of Chronic Hepatitis B Infection

(2012) Wai-Kay Seto et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B

(2012) Wai-Kay Seto et al.   PLoS One

Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety

(2011) Man-Fung Yuen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

(2011) James Fung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters

(2011) Tai–Chung Tseng et al.   GASTROENTEROLOGY

Report on a single-topic conference on “Chronic Viral Hepatitis-Strategies to Improve Effectiveness of Screening and Treatment”

(2011) John W. Ward et al.   HEPATOLOGY

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

(2011) Roeland Zoutendijk et al.   HEPATOLOGY

Acute-on-chronic liver failure in chronic hepatitis B

(2011) Wai-Kay Seto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

(2011) Roeland Zoutendijk et al.   JOURNAL OF INFECTIOUS DISEASES

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

(2010) Maurizia Rossana Brunetto et al.   GASTROENTEROLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

(2010) Tin Nguyen et al.   JOURNAL OF HEPATOLOGY

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

(2010) Jerzy Jaroszewicz et al.   JOURNAL OF HEPATOLOGY

Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome

(2010) Wai-Kay Seto et al.   JOURNAL OF HEPATOLOGY

Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

(2010) Emanuel K. Manesis et al.   JOURNAL OF HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

(2008) Rami Moucari et al.   HEPATOLOGY

Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

(2007) Jean–Michel Pawlotsky et al.   GASTROENTEROLOGY